Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Cipher Pharmaceuticals Schedules Q1 2022 Earnings Release and Conference Call

T.CPH

OAKVILLE, ON, May 9, 2022 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) ("Cipher" or "the Company") today announced that it will release its Q1 2022 financial results on Thursday, May 12, 2022 after market close. The Company will also host a conference call on Friday, May 13, 2022 at 8:30am ET to discuss the results and corporate developments.

CONFERENCE CALL DETAILS

DATE:

May 13, 2022

TIME:

8:30 a.m. ET

DIAL-IN NUMBER:

(647) 484-0477 or (888) 458-4121

CONFERENCE ID:

6137413

REPLAY DIAL-IN:

(888) 203-1112 (playback 6137413#)


Expires May 20, 2022

WEBCAST:

https://produceredition.webcasts.com/starthere.jsp?ei=1548662&tp_key=a2eab0e46f

About Cipher Pharmaceuticals Inc.

Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.

SOURCE Cipher Pharmaceuticals Inc.

Cision View original content: http://www.newswire.ca/en/releases/archive/May2022/09/c9976.html